Drug Interaction Report
1 potential interaction and/or warning found for the following 2 drugs:
- Eysuvis (loteprednol ophthalmic)
- tucatinib
Interactions between your drugs
loteprednol ophthalmic tucatinib
Applies to: Eysuvis (loteprednol ophthalmic), tucatinib
Tucatinib may increase the blood levels of loteprednol ophthalmic. You may be more likely to experience side effects such as swelling, weight gain, high blood pressure, high blood glucose, muscle weakness, depression, acne, thinning skin, stretch marks, easy bruising, bone density loss, cataracts, menstrual irregularities, excessive growth of facial or body hair, and abnormal distribution of body fat, especially in the face, neck, back, and waist. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. Other side effects that may occur include decreased ability to fight infections, increased risk of developing infections, and inadequate response to stress such as infection, surgery, trauma, or a severe asthma attack. Children may experience a reduced growth rate due to excessive effects of loteprednol ophthalmic. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Chantix
Chantix is a smoking cessation medicine used with behavior modification and counseling to help you ...
Restasis
Restasis is used to treat chronic dry eye that may be caused by inflammation. Learn about side ...
Ubrelvy
Ubrelvy (ubrogepant) tablets are used for the acute treatment of migraine. Includes Ubrelvy side ...
Xiidra
Xiidra (lifitegrast 5%) is an eye drop solution that is used twice daily in each eye to treat the ...
Miebo
Miebo (perfluorohexyloctane) is used to treat the signs and symptoms of dry eye disease. Includes ...
Cequa
Cequa (cyclosporine ophthalmic) is a prescription eye drop used to treat chronic dry eye from ...
Lotemax
Lotemax and Lotemax SM (loteprednol etabonate) are corticosteroid medications used to help treat ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.